Tender Details

Country: USA
Summary: Serum Collection from Patients with Borrelia Miyamotoi Disease
UST Ref No: 71080954
Deadline: 08 Sep 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 2022-67130
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
The purpose of this procurement is to obtain clinical specimens from well-characterized patients with Borrelia miyamotoi disease from the upper midwest (Wisconsin, Minnesota), northeast (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont) or mid-Atlantic (New Jersey, New York, Pennsylvania) states as well as supporting clinical and laboratory information to expand a standardized national repository of serum samples for the development of improved serologic tests for Lyme disease and Borrelia miyamotoi disease. This repository and database of clinical information will be maintained by the Division of Vector-Borne Diseases, CDC. This serum bank will be available for external requestors for use in developing and evaluating improved serologic tests.
This effort will allow CDC to broadly support the development and validation of improved serologic assays for Lyme disease and Borrelia miyamotoi disease by providing well-characterized positive control serum samples from patients with Borrelia miyamotoi disease and anonymized clinical information to qualified investigators. Specifically, these sera will enhance the development of Lyme serologic tests with improved specificity and the development of Borrelia miyamotoi serologic tests with improved sensitivity and specificity.
SCOPE OF WORK
This scope of work pertains to a non-severable contract with a health care institution or medical care provider within the upper midwest (Minnesota, Wisconsin), northeast (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont) or mid-Atlantic (New Jersey, New York, Pennsylvania) states where cases of B. miyamotoi disease have been previously confirmed by PCR testing. Obtain and deliver to CDC, two serum samples of approximately 15 mL each, collected at least 30 days apart, from at least 10 individuals with well-characterized (both clinical and laboratory data) Borrelia miyamotoi disease. The vendor will secure Institutio...
Documents:

A19.75D30122Q75361-08.17.2022.doc

If you are registered member, kindly login to view full details of this tender notice:

Serum Collection from Patients with Borrelia Miyamotoi Disease - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Serum Collection from Patients with Borrelia Miyamotoi Disease. This tender is published on USARFP under UST Ref No: 71080954 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-09-08.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.